Article

Molecular diagnosis and prognosis of cancers of unknown-primary (CUPs): progress from a microRNA-based droplet digital PCR assay

2021-02-03

Abstract excerpt

Metastasis is responsible for the majority of cancer-related deaths. Particularly challenging is the management of metastatic cancer of unknown primary site (CUP), whose tissue-of-origin (TOO) remains undetermined even after expensive investigations. CUP therapy is rather unspecific and poorly effective. Molecular approaches developed to identify CUPs’ potential tissue-of-origin, can overcome some of these issues....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b8d047e8-1c43-58db-aa06-34ccc9d63e48
DOI: 10.1101/2021.02.03.429509

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Molecular diagnosis and prognosis of cancers of unknown-primary (CUPs): progress from a microRNA-based droplet digital PCR assayDOI 10.1101/2021.02.03.429509Read

MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primarySemantic proximity Read

MicroRNA profiling for the identification of cancers with unknown primary tissue‐of‐originSemantic proximity Read

A Second-Generation MicroRNA-Based Assay for Diagnosing Tumor Tissue OriginSemantic proximity Read

Deep Learning Based Identification of Tissue of Origin for Carcinomas of Unknown Primary utilizing micro-RNA expressionSemantic proximity Read

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report.Semantic proximity Read

Cancer of unknown primary: the evolution of tissue of origin identification in the artificial intelligence eraSemantic proximity Read

Cancer of unknown primary.Semantic proximity Read

A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primarySemantic proximity Read

Implementation of a novel microarray‐based diagnostic test for cancer of unknown primarySemantic proximity Read

Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?Semantic proximity Read

An Expression-Based Site of Origin Diagnostic Method Designed for Clinical Application to Cancer of Unknown OriginSemantic proximity Read

Exploring the molecular landscape of cancer of unknown primary: A comparative analysis with other metastatic cancers.Semantic proximity Read